NOVARTIND logo

Novartis India Limited

NOVARTIND·NSE·
1,577.80 -4.30 (-0.27%)
Market Cap3943.61 Cr
PE Ratio41.81
Volume4,605
Day High - Low1600.00 - 1560.20
52W High-Low1780.00 - 672.25
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
11.38%
Average
P/E
41.81x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day1560
1600
52W672.25
1780
DocStoX take

Supported by risk (7.8) and momentum (7.5), but held back by valuation (0.5). Risk looks strong at 7.8, but that is offset by valuation at 0.5. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.6
/10
Fair
Quality
Solid
ROE 11.4%
Valuation
Expensive
P/E 41.8×
Growth
Steady
Revenue -1.4% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Strong
82% of 52-week range

At a glance

Market Cap
₹3,944 Cr
52W High / Low
₹1780 / ₹672
Dividend Yield
1.68%
Promoter Holding
70.68%
EPS (TTM)
₹37.74
Book Value
₹331.54

Key highlights

  • Profit compounding 35% a year
  • Low leverage — D/E 0.00
  • Healthy net margin (26%)
  • Revenue shrinking 1% a year
  • Valuation is weak (0.5/10)
3 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

NOVARTIS INDIA LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.